3 Small Biotechs on the FDA Summer Calendar

I hope all had a relaxing and joyous Fourth of July holiday. Today is the first full day of trading in the second half of 2017. Biotech had a solid first half of the year, rising more than 10% and recently moving through upward resistance levels that had been in place since very late in 2015. I find it impressive that this area of the market was able to climb despite merger-and-acquisition activity. After underperforming the market significantly over the past two years, I think the sector is set up for continued gains in the back half of 2017.

There are a few key events over the summer for several small biotech stocks I have profiled often on these pages. These milestones definitely could impact these stocks over the summer, so today we'll summarize some items to be aware over the coming months....351 more words left in this article. To read them, just click below and try Real Money FREE for 14 days.

Read the full story and get access to the Real Money Pro trading floor.

There’s no substitute for a trading floor to get great ideas, so Jim Cramer created a better one at Real Money and blogs there exclusively. We then added legendary hedge fund manager, Doug Kass, with his exclusive Daily Diary and best investing ideas. Staffed with more than 4 dozen investing pros, money managers, journalists and analysts, Real Money Pro gives you a flood of opinions, analysis and actionable trading advice found nowhere else, and allows you to interact directly with each expert.

Already a Subscriber? Please login.

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.